Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep429 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

The management of nonalcoholic fatty liver disease with a choline containing antioxidant compound

Athanassiou Panagiotis , Athanassiou Lambros , Kotrotsios Anastasios , Gatsiou Marina , Tsakiridis Pavlos , Devetzi Eirini , Mavroudi Maria , Kaiafa Georgia , Savopoulos Christos , Kostoglou-Athanassiou Ifigenia

Nonalcoholic fatty liver disease has an increased worldwide prevalence due to obesity and the use of various drugs affecting the liver. The pathogenesis of nonalcoholic fatty liver disease is presently not completely defined. In addition, there is a paucity of agents for its treatment. Choline deficiency has been shown to induce nonalcoholic liver disease. Systemic autoimmune rheumatic diseases require chronic systemic treatment with various agents, which may affect liver func...